BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2404 related articles for article (PubMed ID: 12682443)

  • 1. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.
    Idell S
    Crit Care Med; 2002 May; 30(5 Suppl):S274-80. PubMed ID: 12004248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extravascular coagulation and fibrin deposition in acute lung injury.
    Idell S
    New Horiz; 1994 Nov; 2(4):566-74. PubMed ID: 7804805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases.
    Wygrecka M; Jablonska E; Guenther A; Preissner KT; Markart P
    Thromb Haemost; 2008 Mar; 99(3):494-501. PubMed ID: 18327397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia.
    Levi M; Schultz MJ; Rijneveld AW; van der Poll T
    Crit Care Med; 2003 Apr; 31(4 Suppl):S238-42. PubMed ID: 12682446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult respiratory distress syndrome: do selective anticoagulants help?
    Idell S
    Am J Respir Med; 2002; 1(6):383-91. PubMed ID: 14720025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury.
    Idell S; Peterson BT; Gonzalez KK; Gray LD; Bach R; McLarty J; Fair DS
    Am Rev Respir Dis; 1988 Nov; 138(5):1282-94. PubMed ID: 3202484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of bronchoalveolar hemostasis in the pathogenesis of acute lung injury.
    Hofstra JJ; Haitsma JJ; Juffermans NP; Levi M; Schultz MJ
    Semin Thromb Hemost; 2008 Jul; 34(5):475-84. PubMed ID: 18956288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and inflammation in acute lung injury.
    Welty-Wolf KE; Carraway MS; Ortel TL; Piantadosi CA
    Thromb Haemost; 2002 Jul; 88(1):17-25. PubMed ID: 12152667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of urokinase plasminogen activator (uPA) activity by E-cadherin and hormones in mammary epithelial cells.
    Sasaki CY; Lin H; Passaniti A
    J Cell Physiol; 1999 Oct; 181(1):1-13. PubMed ID: 10457348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
    Idell S; Zwieb C; Kumar A; Koenig KB; Johnson AR
    Am J Respir Cell Mol Biol; 1992 Oct; 7(4):414-26. PubMed ID: 1389210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
    J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.
    Shetty S; Padijnayayveetil J; Tucker T; Stankowska D; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2008 Dec; 295(6):L967-75. PubMed ID: 18836029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of coagulation factors in acute lung injury.
    Russell JA
    Crit Care Med; 2003 Apr; 31(4 Suppl):S243-7. PubMed ID: 12682447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant therapy in acute lung injury.
    Laterre PF; Wittebole X; Dhainaut JF
    Crit Care Med; 2003 Apr; 31(4 Suppl):S329-36. PubMed ID: 12682461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.
    Barazzone C; Belin D; Piguet PF; Vassalli JD; Sappino AP
    J Clin Invest; 1996 Dec; 98(12):2666-73. PubMed ID: 8981909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of endogenous fibrinolysis does not reduce local fibrin deposition, but modulates inflammation upon intestinal ischemia and reperfusion.
    Schoots IG; Levi M; van Vliet AK; Declerck PJ; Maas AM; van Gulik TM
    Thromb Haemost; 2004 Mar; 91(3):497-505. PubMed ID: 14983225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 121.